Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan

Emerging Infectious Diseases, June, 2005 by Jing-Jou Yan, Chien-Shun Chiou, Tsai-Ling Yang Lauderdale, Shu-Huei Tsai, Jiunn-Jong Wu

Table 1. Resistance to ciprofloxacin, extended-spectrum
cephalosporins, and both in Salmonella enterica serotypes,
by region and pulsotype, Taiwan, January-May 2004

                        No. of resistant S. enterica
                     isolates/no. of total isolates (%)

Resistance and
region *            Enteritidis   Typhimurium    Stanley

Ciprofloxacin       1/161 (0.6)    0/142 (0)     0/53 (0)
resistance
  Northern           0/96 (0)      0/38 (0)      0/14 (0)
  Central           1/32 (3.1)     0/34 (0)      0/14 (0)
  Southern           0/25 (0)      0/60 (0)      0/24 (0)
  Eastern             0/8 (0)      0/10 (0)      0/1 (0)
ESC resistance       0/161 (0)     0/142 (0)    3/53 (5.7)
  Northern           0/96 (0)      0/38 (0)     1/14 (7.1)
  Central            0/32 (0)      0/34 (0)     1/14 (7.1)
  Southern           0/25 (0)      0/60 (0)     1/24 (4.2)
  Eastern             0/8 (0)      0/10 (0)      0/1 (0)
Ciprofloxacin and    0/161 (0)     0/142 (0)     0/53 (0)
ESC resistance
  Northern           0/96 (0)      0/38 (0)      0/14 (0)
  Central            0/32 (0)      0/34 (0)      0/14 (0)
  Southern           0/25 (0)      0/60 (0)      0/24 (0)
  Eastern             0/8 (0)      0/10 (0)      0/1 (0)

                          No. of resistant S. enterica
                       isolates/no. of total isolates (%)

                                     Uncommon
Resistance and                      serotypes         All
region *            Choleraesuis    ([dagger])     serotypes

Ciprofloxacin       38/45 (84.4)   11/199 (5.5)   50/600 (8.3)
resistance
  Northern          13/16 (81.3)    6/88 (6.8)    19/252 (7.5)
  Central            6/8 (75.0)    4/37 (10.8)    11/125 (8.8)
  Southern          18/20 (90.0)    1/65 (1.5)    19/194 (9.8)
  Eastern            1/1 (100)       0/9 (0)       1/29 (3.4)
ESC resistance      8/45 (17.8)    9/199 (4.5)    20/600 (3.3)
  Northern           1/16 (6.3)     7/88 (8.0)    9/252 (3.6)
  Central             0/8 (0)       1/37 (2.7)    2/125 (0.8)
  Southern          7/20 (35.0)     1/65 (1.5)    9/194 (4.6)
  Eastern             0/1 (0)        0/9 (0)        0/29 (0)
Ciprofloxacin and   8/45 (17.8)    2/199 (1.0)    10/600 (1.7)
ESC resistance
  Northern           1/16 (6.3)     1/88 (1.1)    2/252 (0.8)
  Central             0/8 (0)       1/37 (2.7)    1/125 (0.8)
  Southern          7/20 (35.0)      0/65 (0)     7/194 (3.6)
  Eastern             0/1 (0)        0/9 (0)        0/29 (0)

                              Pulsotypes of
Resistance and            Choleraesuis isolates
region *                     (no of isolates)

Ciprofloxacin
resistance
  Northern                 A (11), D (1), E (1)
  Central                      A (5), C (1)
  Southern          A (14), B (1), C (1), F (1), G (1)
  Eastern                         A (1)
ESC resistance
  Northern
  Central
  Southern
  Eastern
Ciprofloxacin and
ESC resistance
  Northern                        E (1)
  Central
  Southern              A (4), C (1), F (1), G (1)
  Eastern

* ESC, extended-spectrum cephalosporin.

([dagger]) Includes 197 isolates of 42 uncommon serotypes and 2
untypeable isolates.

Table 2. Characteristics of 20 Salmonella isolates resistant to
extended-spectrum cephalosporins

                                                          gyrA at
                                                          position
                                                         ([dagger])

               Specimen                 Resistance        83 (TCC
Serotype         type      pl (s)        pattern *         [Ser])

Albany          Urine       9.0       Am ESC Fx Cm Na        --
                                     Sxt Tc ([dagger])

Cairo           Stool     9.0, 5.4    Am ESC Fx Cm Na    TTC (Phe)
                                       Gm Km Sxt Tc
                                        ([dagger])

                Urine       9.0       Am ESC Fx Cm Cp    TTC (Phe)
                                         Na Sxt Tc

Chester         Stool       9.0          Am ESC Fx           --

Choleraesuis    Wound     9.0, 5.4    Am ESC Fx Cm Cp    TTC (Phe)
                                      Na Gm Km Sxt Tc

                Blood     9.0, 5.4    Am ESC Fx Cm Cp    TTC (Phe)
                                         Na Gm Tc

                Blood     9.0, 5.4    Am ESC Fx Cm Cp    TTC (Phe)
                                      Na Gm Km Sxt Tc

                Blood     9.0, 5.4    Am ESC Fx Cm Cp    TTC (Phe)
                                       Na Gm Km Sxt
                Joint     9.0, 5.4    Am ESC Fx Cm Cp    TTC (Phe)
                fluid                 Na Gm Km Sxt Tc

Kaduna          Tissue    9.0, 5.4    Am ESC Fx Cm Cp    TTC (Phe)
                                         Na Sxt Tc
Saintpaul       Stool       9.0        Am ESC Fx Gm          --

Stanley         Stool     9.0, 5.4       Am ESC Fx           --
                                         Cm Sxt Tc

                Stool       9.0          Am ESC Fx           --
                                         Cm Sxt Tc

                           gyrA at
                           position
                          ([dagger])

                                                         Isolate
                                                       (restriction
                                         parC at        pattern of
                                       position 80     transferred
                                       (AGC [Ser])   [bla.sub.CMY-2] 
               Specimen    87 (GAC      ([double         plasmid)
Serotype         type       [Asp])      dagger])       ([section])

Albany          Urine     AAC (Asn)        --          SA04.028 (C)

Cairo           Stool         --           --         NC04.001 (H1),
                                                      NC04.002 (H1),
                                                      NC04.003 (H1)

                Urine     GGC (Gly)     AAC (Arg)     NC04.004 (H2)

Chester         Stool         --           --          NG04.016 (G)

Choleraesuis    Wound     AAC (Asn)     ATC (Ile)      NL04.050 (B)

                Blood     AAC (Asn)     ATC (Ile)      SB04.003 (A)

                Blood     AAC (Asn)     ATC (Ile)     SE04.005 (F),
                                                         SG04.060

                Blood     AAC (Asn)     ATC (Ile)     SG04.039 (E1),
                                                         SG04.086

                Joint     AAC (Asn)     ATC (Ile)     SG04.042 (E2),

                fluid                                 SG04.047 (E4)

Kaduna          Tissue    AAC (Asn)     ATC (Ile)      CE04.015 (I)

Saintpaul       Stool         --           --         NG04.011 (G),
                                                       NG04.018 (G)

Stanley         Stool         --           --          CG04.039 (D)

                Stool         --           --         NB04.022 (A),
                                                      SE04.006 (E3)

* Am, ampicillin; ESC, extended-spectrum cephalosporins, Fx,
cefoxitin, Cm, chloramphenicol, Cp, ciprofloxacin; Na, nalidixic acid;
Gm, gentamicin, Km, kanamycin, Sxt, trimethoprim-sulfamethoxazole; Tc,
tetracycline.

([dagger]) The S. Albany isolate and the 3 S. Cairo isolates showed
decreased susceptibilities to ciprofloxacin (MIC 0.25-1 [micro]g/mL).

([double dagger]) Nucleotide and amino acid changes at the QRDRs of
gyrA and parC. --, no alterations in the genes.

([section]) For each isolate, the first letter indicates region (C,
central region; N, northern region, S, southern region), and the
second letter represents hospital. Isolates NC04.001, NC04.002, and
NC04.003 were from the same patients; all other isolates were from
different patients.

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale